Grado, Vina Mae R.
HRN: 09-50-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2026
METRONIDAZOLE 500MG (TAB)
07/08/2026
07/15/2026
PO
500mg
TID
Thickly MSAF
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines